UCBB Eng

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

INDIAN COUNCIL OF MEDICAL RESEARCH

New Delhi - 110029


FAQs on cord blood banking

1. Is umbilical cord blood (UCB) banking service covered under any guidelines/norms in the
country?
Umbilical Cord Blood banks (UCB) are permitted only under license and monitoring by the
Central Drug Standards Controlling Organization (CDSCO). The Cord Blood Banks have to
comply with the Drugs and Cosmetics (3rd Amendment) Rules, Gazette Notification No. GSR
899(E) dated 27/12/2011 for collection, processing, testing, storage, banking, and release of
stored units.
(Available at: http://cdsco.nic.in/html/GSR%20899.pdf).

2. How can one know about the CDSCO licensed banking services available in the country?
The CDSCO website provides the list of all the licensed UCB banks in the country.
http://www.cdsco.nic.in/writereaddata/Umbilical-Cord-Blood-Banks-India.pdf

3. Can banks store tissues other than UCB as a source of stem cells?
No. At present only banking of UCB is permitted. Hence the storage or banking of any other
tissue for example dental pulp, cord tissue, Wharton jelly etc is not permitted.

4. Is there any scientific credibility to storing UCB for future self use?
Several international bodies such as American Academy of Pediatrician, American Society for
Blood and Marrow Transplant, Royal College of Obstetricians and Gynecologists, American
College of Obstetrics and Gynecology, American Medical Association, European Group on Ethics
in Science and New Technologies etc. do not recommend routine private banking for future self
use. The reasons being:
The likelihood of the stored blood being used for HSCT is very small, probably as low as 0.005 to
0.04% in the first 20 yrs of life.
Stem cell transplant using an individual’s own cord blood (autologous transplant) cannot be
recommended for genetic disorders.
The private banking is suggested in cases where there is a relative/sibling with a condition or
there is a family history of malignant or genetic conditions that can be treated with HSC
transplantation. Moreover, banking for allogeneic transplant is recommended when there are
shared HLA antigens between parents.

5. What types of people are choosing to have the UCB banked?


Initially, the banking started in the metro urban class people who could afford the cost of
banking. Now with intensive advertisement by the cord blood banks, the upper middle and
middle class is getting aware about banking and opting for it even in smaller cities and towns.

6. What are the concerns regarding the advertisements by cord blood banks?
The misleading and luring advertisement by private cord blood banks is an area of major
concern. Such ads often involve celebrities as their brand ambassador’s prompting storage as
status symbol because celebrities are doing the same. The expectant parents venture under the
influence of such advertisement without knowledge about possible self or family use. They are
emotionally as well as economically burdened to store the child’s UCB as a form of biological
insurance for future use. The advertisements are misleading the public into believing that the
child’s own UCB can protect it from the 80 different medical conditions and this statement is not
scientifically supported. Another propaganda made on the websites of the private banks is the
utility of stem cells in several incurable diseases (unproven conditions) through blogs and
testimonials of patients and doctors. This again is a catch 22 situation for the expectant parents
who are made to think that they are depriving the child of future panacea by not storing the
UCB. Moreover, banks also indulge in practices like following up the expectant mother and
healthcare professionals offering them incentives to for availing the facilities.

7. What are the general concerns regarding banking practices/ Are people being taken advantage
of?
Yes. As mentioned above/Parents are not given accurate information regarding utility of stored
tissue. There is no clarity if the tissues stored are viable, as there have been several instances
when the tissues were asked for transplantation, they were found to be without any viable cells.
The customer has no idea what happens to the stored unit if the facilities closes or in natural
calamities. There are several gray areas that need to be addressed.

8. Where can one complaint against the UCB banks?


Complaints regarding unethical practices can be made to zonal offices of CDSCO with copy to
central CDSCO and ICMR. One can also move to consumer court.

9. Which company/banks should the baby’s UCB be stored?


The UCB should be stored only in the UCB banks that are licensed by CDSCO. Regarding which
licensed UCB banks to be chosen, it is solely one’s own judgment to decide on which company is
the best. However, it may be noted that as per National Guidelines for Stem Cell Research -
2017:
Umbilical Cord Blood (UCB) is a rich source of CD34+ hematopoietic and mesenchymal (stromal) stem
cells. Use of UCB derived HSCs for treatment of various haematological and immunological disorders is
currently well established, particularly where an HLA-matched sibling is not available. However, there is
a paucity of public funded UCB banks in India. On the other hand several private banks have come-up,
that engage themselves in promotional advertisements offering storage of cord blood with the promise
of future therapeutic use. Such advertisements are often misleading for the public and lack
comprehensive and accurate information. So far there is no scientific basis for preservation of cord blood
for future self-use and this practice therefore raises ethical and social concerns. Private storage of the
cord blood HSCs is advisable when there is an elder child in the family with a condition treatable with
these cells and the mother is expecting the next baby. In other situations, the parents should be
educated about the limitations of banking at this point of time.

You might also like